524748 — Link Pharmachem Share Price
- IN₹148.67m
- IN₹212.46m
- IN₹298.98m
- 63
- 47
- 36
- 47
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.13 | ||
Price to Tang. Book | 1.13 | ||
Price to Free Cashflow | 25.34 | ||
Price to Sales | 0.57 | ||
EV to EBITDA | 17.15 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.18% | ||
Return on Equity | -3.11% | ||
Operating Margin | 1.17% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 254.71 | 348.13 | 535.61 | 387.58 | 298.98 | n/a | n/a | 4.06% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +127 | -19.95 | +50.95 | -63.6 | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Link Pharma Chem Limited is a chemical manufacturing company. The Company is engaged in manufacturing and exporting multi range intermediates for pharmaceutical, agro-industries and specialty chemicals. It has its manufacturing location at Nandesari in Gujarat. It has one production unit engaged in the manufacturing and job work of organic intermediates. It is also involved in custom synthesis / contract manufacturing for multistage synthesis for small, medium, and large companies. It offers services, such as contract manufacturing facilities, development of multistep pathways for organic synthesis, and refinement and optimization of existing synthetic methods. The Company's in-house testing laboratory has various facilities, such as high-performance liquid chromatography (HPLC) testing facilities, gas liquid chromatography (GLC) testing facilities, ultraviolet spectrophotometer testing facilities, Karl-Fisher instruments for moisture/water content measurement, and others.
Directors
- Sathish Thakur CHM
- Bhushan Joshi CCO
- Rishikesh Thakur MDR
- Suresh Dhatrak IND (60)
- Rachna Ghai IND
- Devang Shah IND
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 28th, 1984
- Public Since
- November 23rd, 1994
- No. of Employees
- 87
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
Bombay Stock Exchange
- Shares in Issue
- 4,440,568

- Address
- 161 - 162, GIDC Estate, Baroda, NANDESARI, 391340
- Web
- http://www.linkpharmachem.co.in/
- Phone
- +91 2652840448
- Auditors
- CNK & Associates LLP
Upcoming Events for 524748
Similar to 524748
3B Blackbio DX
Bombay Stock Exchange
A-1
Bombay Stock Exchange
Add-Shop E-Retail
Bombay Stock Exchange
Advance Petrochemicals
Bombay Stock Exchange
Advance Syntex
Bombay Stock Exchange
FAQ
As of Today at 21:47 UTC, shares in Link Pharmachem are trading at IN₹34.78. This share price information is delayed by 15 minutes.
Shares in Link Pharmachem last closed at IN₹34.78 and the price had moved by -22.59% over the past 365 days. In terms of relative price strength the Link Pharmachem share price has underperformed the S&P BSE 100 Index by -27.08% over the past year.
There is no consensus recommendation for this security.
Find out moreLink Pharmachem does not currently pay a dividend.
Link Pharmachem does not currently pay a dividend.
Link Pharmachem does not currently pay a dividend.
To buy shares in Link Pharmachem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹34.78, shares in Link Pharmachem had a market capitalisation of IN₹148.67m.
Here are the trading details for Link Pharmachem:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524748
Based on an overall assessment of its quality, value and momentum Link Pharmachem is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Link Pharmachem. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -11.25%.
As of the last closing price of IN₹34.78, shares in Link Pharmachem were trading -14.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Link Pharmachem PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹34.78.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Link Pharmachem's management team is headed by:
- Sathish Thakur - CHM
- Bhushan Joshi - CCO
- Rishikesh Thakur - MDR
- Suresh Dhatrak - IND
- Rachna Ghai - IND
- Devang Shah - IND